- Scemblix (asciminib) Tablets
Date of Approval: October 29, 2021
Treatment for: Chronic Myelogenous Leukemia
Press Release | Approval History - Vuity (pilocarpine hydrochloride) Ophthalmic Solution
Date of Approval: October 28, 2021
Treatment for: Presbyopia
Press Release | Approval History - Susvimo (ranibizumab) Injection for Intravitreal Use via Ocular Implant
Date of Approval: October 25, 2021
Treatment for:
Press Release | Approval History - Xipere (triamcinolone acetonide) Injection
Date of Approval: October 22, 2021
Treatment for: Macular Edema, Uveitis
Press Release | Approval History - Zimhi (naloxone hydrochloride) Injection
Date of Approval: October 15, 2021
Treatment for: Opioid Overdose
Press Release | Approval History - Seglentis (celecoxib and tramadol hydrochloride) Tablets
Date of Approval: October 15, 2021
Treatment for: Pain
Press Release | Approval History - Tyrvaya (varenicline) Nasal Spray
Date of Approval: October 15, 2021
Treatment for: Dry Eye Disease
Press Release | Approval History - Rethymic (allogeneic processed thymus tissue-agdc) for Surgical Implantation
Date of Approval: October 8, 2021
Treatment for: Congenital Athymia
Press Release | Approval History - Tavneos (avacopan) Capsules
Date of Approval: October 7, 2021
Treatment for: ANCA-Associated Vasculitis
Press Release | Approval History
Wednesday, November 3, 2021
New Drug Approvals
Subscribe to:
Post Comments (Atom)
-
This is the fourth in a series of posts based upon Jordan Peterson's book Maps of Meaning, published in 1999 after 17 years of researc...
No comments:
Post a Comment